Eribulin

Acknowledgment: Data collected from https://www.totalpatentone.com/   Date Abstract Patent Application 2009-03-30 The present invention provides a novel liposome composition containing eribulin or its pharma¬cologically permissible salt, and its method of manufacture. IN6850DELNP2011A 2010-01-26 In general the invention features compounds useful for the
Read More

Patent – Need or Greed?

Pharmaceutical companies are constantly delivering on its promise to fight diseases that are still incurable, including cancer, Alzheimer’s disease, multiple sclerosis, amongst others. IPR protection is a key requirement to keep the funds flowing so that more innovation can be done. Innovation
Read More